drugset / Trial / NCT00872378
The Effects of Exenatide After Gastric Restriction
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to describe change in body weight in non-diabetic morbidly obese patients after laparoscopic adjustable gastric banding (LAGB) with twice daily exenatide or placebo injections.
Timeline
- Start
- 2009-02
- Primary completion
- 2010-12
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Exenatide | Peptide | 20 ug | — |